Cargando…
Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
Scleromyxedema is a rare and progressive disease that currently has no standard treatment. Triplet therapy with lenalidomide, bortezomib, and dexamethasone can be an effective therapy for scleromyxedema, especially in patients with refractory or relapsed disease.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752349/ https://www.ncbi.nlm.nih.gov/pubmed/33363876 http://dx.doi.org/10.1002/ccr3.3302 |